↓ Skip to main content

Cochrane Database of Systematic Reviews

Fluvoxamine for the treatment of COVID-19

Overview of attention for article published in Cochrane database of systematic reviews, September 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
26 tweeters
facebook
1 Facebook page

Readers on

mendeley
22 Mendeley
Title
Fluvoxamine for the treatment of COVID-19
Published in
Cochrane database of systematic reviews, September 2022
DOI 10.1002/14651858.cd015391
Pubmed ID
Authors

John LZ Nyirenda, Mario Sofroniou, Ingrid Toews, Agata Mikolajewska, Cornelius Lehane, Ina Monsef, Aesha Abu-taha, Andy Maun, Miriam Stegemann, Christine Schmucker

Twitter Demographics

The data shown below were collected from the profiles of 26 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 9%
Student > Bachelor 2 9%
Student > Master 2 9%
Other 1 5%
Researcher 1 5%
Other 0 0%
Unknown 14 64%
Readers by discipline Count As %
Medicine and Dentistry 3 14%
Unspecified 2 9%
Immunology and Microbiology 1 5%
Environmental Science 1 5%
Economics, Econometrics and Finance 1 5%
Other 1 5%
Unknown 13 59%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2022.
All research outputs
#2,337,816
of 22,564,083 outputs
Outputs from Cochrane database of systematic reviews
#4,948
of 12,279 outputs
Outputs of similar age
#48,092
of 424,423 outputs
Outputs of similar age from Cochrane database of systematic reviews
#69
of 126 outputs
Altmetric has tracked 22,564,083 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,279 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.2. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,423 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 126 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.